# Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients

> **NCT00643825** · PHASE2 · UNKNOWN · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 64 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Temozolomide
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT00643825
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2011-01
- **Final completion:** 2012-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2010-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643825, "Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00643825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*